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In this paper, we studied the effects of addition of PGE1 from the view point of von Willebrand factor (vWF) in stored platelet in vitro, and the results as follows; 1) From the inhibition of the changes of mean platelet volume and leaking of LDH under hypotonic shock, optimal concentration of PGE1 was 0.4pg/ml (f. c.). 2) Aggregability in platelets for 4 days storage was more potential in PGE1 group than in control group.
3) The quantitative changes in antigenicity and ristocetin cofactor activity of vWF in plasma were not detectable, but these in platelets were reduced in the course of storage. The addition of PGE1 to PRP was able to prevent these changes. The qualitive changes of vWF in stored platelets were seen more slightly in PGE1 group. 4) In PGE1 group, platelet adhesiveness measured by Baumgartner's method was also superior to control group.
From above results, it is suggested that maintenance of viability in stored platelets by the addition of PGE1 partly depends on prevention the deterioration of vWF in platelets. 18: 149 
